OpenVSafe by OpenVAERS
Search V-safe

27S-33874-76388

2 vaccinations 2 coded responses 21 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
844 / UT
Registered
2021-11-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-15
    Registered in v-safe
  2. 2021-11-15
    Dose 1 — Pfizer-BioNTech
  3. 2021-11-15
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-11-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2021-11-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-11-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-11-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-11-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Nausea
    Adult check-in
  9. 2021-11-22
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-11-29
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-12-06
    Dose 2 — Pfizer-BioNTech
  12. 2021-12-06
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  13. 2021-12-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Syncope — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Faint
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  15. 2021-12-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose decreased — Feeling: Fair · Fatigue or tiredness
    Free text: Low blood sugar
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-12-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Fatigue or tiredness
    Adult check-in
  17. 2021-12-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-12-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-12-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-12-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-01-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2022-01-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-01-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-03-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-11-15Pfizer-BioNTech No
22021-12-06Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 2

2021-12-07

Systemic reaction (other): Faint

2021-12-09

Systemic reaction (other): Low blood sugar

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROBlood glucose decreased · · ✓
SROSyncope · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…